People's United Financial’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-576
Closed -$217K 632
2021
Q4
$217K Sell
576
-236
-29% -$91.7K 0.01% 638
2021
Q3
$335K Sell
812
-85
-9% -$35.3K 0.01% 593
2021
Q2
$332K Sell
897
-1
-0.1% -$334 0.01% 588
2021
Q1
$260K Buy
898
+33
+4% +$9.17K 0.01% 624
2020
Q4
$216K Buy
+865
New +$206K 0.01% 624

Other funds holding CRL

People's United Financial's CRL Position: Q1 2022 in Review

People's United Financial sold out of Charles River Laboratories (CRL) in Q1 2022, closing a stake of 576 shares — an estimated $217K sold.

People's United Financial first reported a position in CRL in Q4 2020 and held it in 5 quarters. The position peaked at $335K in Q3 2021. 645 funds tracked by Wall St. Rank hold CRL as of Q1 2022.

  • People's United Financial reported no remaining Charles River Laboratories position as of Q1 2022 after selling out during the quarter.
  • People's United Financial sold 576 Charles River Laboratories shares in Q1 2022, an estimated $217K.
  • People's United Financial first reported a position in Charles River Laboratories in Q4 2020 and held it in 5 quarters.
  • People's United Financial's Charles River Laboratories position peaked at $335K in Q3 2021.
  • 645 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2022.

Based on People's United Financial's 13F filing for Q1 2022, filed 10 May 2022.